Anticholinergic Burden in the Elderly Population: An Emerging Concern

Hudson Pierce; Dominique Thomas; Tirsit Asfaw; Bilal Chughtai

doi:10.1016/j.eururo.2019.03.021

Anticholinergic Burden in the Elderly Population: An Emerging Concern

Eur Urol. 2019 Jul;76(1):7-8. doi: 10.1016/j.eururo.2019.03.021. Epub 2019 Mar 28.

Authors

Hudson Pierce¹, Dominique Thomas¹, Tirsit Asfaw¹, Bilal Chughtai²

Affiliations

¹ Department of Urology, Weill Cornell Medicine, New York, NY, USA.
² Department of Urology, Weill Cornell Medicine, New York, NY, USA. Electronic address: bic9008@med.cornell.edu.

PMID: 30930060
DOI: 10.1016/j.eururo.2019.03.021

Abstract

Antimuscarinics are commonly used to treat overactive bladder, but increase anticholinergic burden, which has been associated with multiple adverse outcomes in older patients. We advocate for standardization of anticholinergic risk assessment and reevaluation of anticholinergic prescribing practices for the elderly.

Publication types

Editorial

MeSH terms

Aged
Cognition Disorders / chemically induced*
Dementia / chemically induced*
Drug Interactions
Humans
Muscarinic Antagonists / adverse effects*
Muscarinic Antagonists / pharmacology
Urinary Bladder, Overactive / drug therapy*

Substances

Muscarinic Antagonists